Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Ibn Alhaytham Hospital's cash to debt ratio for the quarter that ended in Jun. 2026 was 0.01.
If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Ibn Alhaytham Hospitalcouldn't pay off its debt using the cash in hand for the quarter that ended in Jun. 2026.
The historical rank and industry rank for Ibn Alhaytham Hospital's Cash-to-Debt or its related term are showing as below:
AMM:IBNH'
s Cash-to-Debt Range Over the Past 10 Years
Min: 0.01 Med: 0.04 Max: 0.26
Current: 0.01
During the past 13 years, Ibn Alhaytham Hospital's highest Cash to Debt Ratio was 0.26. The lowest was 0.01. And the median was 0.04.
AMM:IBNH's Cash-to-Debt is not ranked
in the Healthcare Providers & Services industry.
Industry Median: 0.8
vs AMM:IBNH: 0.01
Ibn Alhaytham Hospital (AMM:IBNH) Cash-to-Debt Explanation
If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.
Ibn Alhaytham Hospital Cash-to-Debt Related Terms
Ibn Alhaytham Hospital Cash-to-Debt Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
AMM:IBNH vs HCA, THC, DVA: Cash-to-Debt Comparison
For the Medical Care Facilities subindustry, Ibn Alhaytham Hospital's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ibn Alhaytham Hospital Cash-to-Debt vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Ibn Alhaytham Hospital's Cash-to-Debt distribution charts can be found below:
* The bar in red indicates where Ibn Alhaytham Hospital's Cash-to-Debt falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ibn Alhaytham Hospital (AMM:IBNH) has a Cash-to-Debt of 0.01 as of Jun. 2026. This is 75% below median its historical median of 0.04. Over the past decade, Ibn Alhaytham Hospital's Cash-to-Debt has ranged from 0.01 to 0.26.
Is Ibn Alhaytham Hospital's Cash-to-Debt too high?
Ibn Alhaytham Hospital's current Cash-to-Debt of 0.01 is 75% below median its 10-year median of 0.04. Over the past 10 years, this metric has ranged from a low of 0.01 to a high of 0.26. The Healthcare Providers & Services industry median Cash-to-Debt is 0.80. Ibn Alhaytham Hospital's value of 0.01 is 98.8% below this industry median. Overall, Ibn Alhaytham Hospital has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.
How does Ibn Alhaytham Hospital's Cash-to-Debt compare to HCA and THC?
Ibn Alhaytham Hospital's Cash-to-Debt of 0.01 can be compared against companies in the Healthcare Providers & Services industry. The industry median Cash-to-Debt is 0.80. Ibn Alhaytham Hospital's value of 0.01 is 98.8% below this benchmark. Historically, Ibn Alhaytham Hospital's own Cash-to-Debt has ranged from 0.01 to 0.26 over the past decade. While the company's 10-year median is 0.04 vs. the industry median of 0.80, Ibn Alhaytham Hospital has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash-to-Debt for a Healthcare Providers & Services company?
The median Cash-to-Debt among Healthcare Providers & Services companies is 0.80, based on 671 companies in the industry. Companies in the top quartile (top 25%) have a Cash-to-Debt significantly above this median, while those in the bottom quartile fall well below. However, Cash-to-Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ibn Alhaytham Hospital's current Cash-to-Debt of 0.01 is 98.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash-to-Debt mean?
A high Cash-to-Debt can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median Cash-to-Debt is 0.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ibn Alhaytham Hospital's current Cash-to-Debt is 0.01, which is 75% below median its own 10-year median of 0.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ibn Alhaytham Hospital stock overvalued right now?
Ibn Alhaytham Hospital (AMM:IBNH) has a current Cash-to-Debt of 0.01. The stock's GF Value™ is JOD0.81, compared to a current price of JOD0.82 — trading 1.2% above its estimated fair value. The current Cash-to-Debt is 0.01, which is 75% below median its 10-year median of 0.04 and 98.8% below the Healthcare Providers & Services industry median of 0.80. Ibn Alhaytham Hospital's overall GF Score™ is 27/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash-to-Debt calculated?
Cash-to-Debt is calculated from a company's financial statements. For Ibn Alhaytham Hospital (AMM:IBNH), the current Cash-to-Debt is 0.01 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ibn Alhaytham Hospital (AMM:IBNH) Overvalued in 2026?
Based on GuruFocus' analysis, Ibn Alhaytham Hospital stock appears to be overvalued.
The current stock price of JOD0.82 is trading 1.2% above its estimated GF Value™ of JOD0.81.
Key valuation signals for AMM:IBNH:
Cash-to-Debt: 0.01 (75% below median its 10-year median of 0.04)
GF Value™: JOD0.81 vs. price of JOD0.82 (1.2% above fair value)
Industry Position: 98.8% below the Healthcare Providers & Services median
No single metric tells the full story. See the AMM:IBNH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ibn Alhaytham Hospital operates as a hospital in Jordan. The Company's main objectives is to found and establish a hospital for general casses And especially ophthalmology, Otorhinolaryngology, Medicine and Neurosurgery and to Import a necessary medical equipment and supplies. The company operates in segments, which comprise of Medical & investments and others.
27GF Score
Get the complete analysis for AMM:IBNH
Cash-to-Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AMM:IBNH has been successfully added to your 
